Erratum to: Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis (The FASEB Journal, (2015), 29, 3, (1029-1042), 10.1096/fj.14-258459);Selective delivery of IFN-γ to renal interstitial myofibroblasts: A novel strategy for the treatment of renal fibrosis

FASEB Journal

Volumn 29, Issue 3, 2015, Pages 1029-1042

  Poosti, Fariba ^a   Bansal, Ruchi ^c   Yazdani, Saleh ^a,c   Prakash, Jai ^c   Post, Eduard ^b   Klok, Pieter ^a   Van Den Born, Jacob ^a   De Borst, Martin H ^a   Van Goor, Harry ^a   Poelstra, Klaas ^b   Hillebrands, Jan Luuk ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Drug targeting; Kidney; PDGFR ; Unilateral ureteral obstruction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 A1; COLLAGEN TYPE 1 A2; FIBRONECTIN; MACROGOL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROCOLLAGEN; RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN;

3T3 CELL LINE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC ACTIVITY; ARTICLE; BRAIN TISSUE; CAPILLARY DENSITY; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY INTERSTITIUM CELL; KIDNEY PARENCHYMA; KIDNEY PRESERVATION; LYMPHANGIOGENESIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; OBSTRUCTION-INDUCED RENAL FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; URETER OBSTRUCTION; ANIMAL; APOPTOSIS; BRAIN; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; ENZYME IMMUNOASSAY; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOPRECIPITATION; KIDNEY DISEASES; MACROPHAGE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; CELL PROLIFERATION; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTERFERON-ALPHA; KIDNEY DISEASES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MYOFIBROBLASTS; NIH 3T3 CELLS; POLYETHYLENE GLYCOLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84937435315     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.202302340     Document Type: Erratum

References (66)

1. Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K. U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., Powe, N. R., Rossert, J., Wheeler, D. C., Lameire, N., and Eknoyan, G. (2007) Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 72, 247-259
2. Friedman, S. L., Sheppard, D., Duffield, J. S., and Violette, S. (2013) Therapy for fibrotic diseases: nearing the starting line. Sci. Transl. Med. 5, 167sr1
3. Duffield, J. S. (2014) Cellular and molecular mechanisms in kidney fibrosis. J. Clin. Invest. 124, 2299-2306
4. Eddy, A. A. (2000) Molecular basis of renal fibrosis. Pediatr. Nephrol. 15, 290-301
5. Meran, S., and Steadman, R. (2011) Fibroblasts and myofibroblasts in renal fibrosis. Int. J. Exp. Pathol. 92, 158-167
6. Boor, P., Ostendorf, T., and Floege, J. (2010) Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat. Rev. Nephrol. 6, 643-656
7. LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., and Kalluri, R. (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047-1053
8. Zeisberg, M., and Kalluri, R. (2004) The role of epithelial-to-mesenchymal transition in renal fibrosis. J. Mol. Med. 82, 175-181
9. Chang, F. C., Chou, Y. H., Chen, Y. T., and Lin, S. L. (2012) Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis. J. Formos. Med. Assoc. 111, 589-598
10. Chen, Y. T., Chang, F. C., Wu, C. F., Chou, Y. H., Hsu, H. L., Chiang, W. C., Shen, J., Chen, Y. M., Wu, K. D., Tsai, T. J., Duffield, J. S., and Lin, S. L. (2011) Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 80, 1170-1181
11. Lin, S. L., Chang, F. C., Schrimpf, C., Chen, Y. T., Wu, C. F., Wu, V. C., Chiang, W. C., Kuhnert, F., Kuo, C. J., Chen, Y. M., Wu, K. D., Tsai, T. J., and Duffield, J. S. (2011) Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am. J. Pathol. 178, 911-923
12. Broekema, M., Harmsen, M. C., van Luyn, M. J., Koerts, J. A., Petersen, A. H., van Kooten, T. G., van Goor, H., Navis, G., and Popa, E. R. (2007) Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J. Am. Soc. Nephrol. 18, 165-175
13. Li, J., Deane, J. A., Campanale, N. V., Bertram, J. F., and Ricardo, S. D. (2007) The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 25, 697-706
14. Li, J., Qu, X., and Bertram, J. F. (2009) Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am. J. Pathol. 175, 1380-1388
15. Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M., and Kalluri, R. (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 2282-2287
16. Weng, H. L., Wang, B. E., Jia, J. D., Wu, W. F., Xian, J. Z., Mertens, P. R., Cai, W. M., and Dooley, S. (2005) Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. Clin. Gastroenterol. Hepatol. 3, 819-828
17. King, T. E., Jr., Albera, C., Bradford, W. Z., Costabel, U., Hormel, P., Lancaster, L., Noble, P. W., Sahn, S. A., Szwarcberg, J., Thomeer, M., Valeyre, D., and du Bois, R. M.; INSPIRE Study Group. (2009) Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 374, 222-228
18. Oldroyd, S. D., Thomas, G. L., Gabbiani, G., and El Nahas, A. M. (1999) Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 56, 2116-2127
19. Lee, J., Lee, J., Park, M. K., Lim, M. A., Park, E. M., Kim, E. K., Yang, E. J., Lee, S. Y., Jhun, J. Y., Park, S. H., Kim, H. Y., and Cho, M. L. (2013) Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase. PLoS One 8, e60900
20. Yao, Y., Zhang, J., Tan, D. Q., Chen, X. Y., Ye, D. F., Peng, J. P., Li, J. T., Zheng, Y. Q., Fang, L., Li, Y. K., and Fan, M. X. (2011) Interferon-gamma improves renal interstitial fibrosis and decreases intrarenal vascular resistance of hydronephrosis in an animal model. Urology 77, 761.e8-761.e13
21. Forbes, M. S., Thornhill, B. A., Minor, J. J., Gordon, K. A., Galarreta, C. I., and Chevalier, R. L. (2012) Fight-or-flight: murine unilateral ureteral obstruction causes extensive proximal tubular degeneration, collecting duct dilatation, and minimal fibrosis. Am. J. Physiol. Renal Physiol. 303, F120-F129
22. Gu, F., Younes, H. M., El-Kadi, A. O., Neufeld, R. J., and Amsden, B. G. (2005) Sustained interferon-gamma delivery from a photo-crosslinked biodegradable elastomer. J. Control. Release 102, 607-617
23. Cleland, J. L., and Jones, A. J. (1996) Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm. Res. 13, 1464-1475
24. Lin, S. L., Kisseleva, T., Brenner, D. A., and Duffield, J. S. (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1627
25. Floege, J., Eitner, F., and Alpers, C. E. (2008) A new look at platelet-derived growth factor in renal disease. J. Am. Soc. Nephrol. 19, 12-23
26. LeBleu, V. S., and Kalluri, R. (2011) Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis. Kidney Int. 80, 1119-1121
27. Ostendorf, T., Eitner, F., and Floege, J. (2012) The PDGF family in renal fibrosis. Pediatr. Nephrol. 27, 1041-1050
28. Seikrit, C., Henkel, C., van Roeyen, C. R., Bokemeyer, D., Eitner, F., Martin, I. V., Boor, P., Knüchel, R., Meyer, H. E., Müller-Newen, G., Eriksson, U., Floege, J., and Ostendorf, T. (2013) Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts. Nephrol. Dial. Transplant. 28, 889-900
29. Bansal, R., Prakash, J., de Ruijter, M., Beljaars, L., and Poelstra, K. (2011) Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis. Mol. Pharm. 8, 1899-1909
30. Bansal, R., Prakash, J., Post, E., Beljaars, L., Schuppan, D., and Poelstra, K. (2011) Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice. Hepatology 54, 586-596
31. Bansal, R., Tomar, T., Ostman, A., Poelstra, K., and Prakash, J. (2012) Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth. Mol. Cancer Ther. 11, 2419-2428
32. Bansal, R., Post, E., Proost, J. H., de Jager-Krikken, A., Poelstra, K., and Prakash, J. (2011) PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis. J. Control. Release 154, 233-240
33. Tapmeier, T. T., Fearn, A., Brown, K., Chowdhury, P., Sacks, S. H., Sheerin, N. S., and Wong, W. (2010) Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int. 78, 351-362
34. Nikolic-Paterson, D. J. (2010) CD4+ T cells: a potential player in renal fibrosis. Kidney Int. 78, 333-335
35. Chade, A. R. (2013) Renal vascular structure and rarefaction. Compr. Physiol. 3, 817-831
36. Rienstra, H., Katta, K., Celie, J. W., van Goor, H., Navis, G., van den Born, J., and Hillebrands, J. L. (2010) Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats. PLoS One 5, e9095
37. Sakamoto, I., Ito, Y., Mizuno, M., Suzuki, Y., Sawai, A., Tanaka, A., Maruyama, S., Takei, Y., Yuzawa, Y., and Matsuo, S. (2009) Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. 75, 828-838
38. Poosti, F., Yazdani, S., Dolman, M. E., Kok, R. J., Chen, C., Ding, G., Lacombe, M., Prakash, J., van den Born, J., Hillebrands, J. L., van Goor, H., and de Borst, M. H. (2012) Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection. Eur. J. Pharmacol. 694, 111-119
39. Yazdani, S., Poosti, F., Kramer, A. B., Mirković, K., Kwakernaak, A. J., Hovingh, M., Slagman, M. C., Sjollema, K. A., de Borst, M. H., Navis, G., van Goor, H., and van den Born, J. (2012) Proteinuria triggers renal lymphangiogenesis prior to the development of interstitial fibrosis. PLoS One 7, e50209
40. Lee, A. S., Lee, J. E., Jung, Y. J., Kim, D. H., Kang, K. P., Lee, S., Park, S. K., Lee, S. Y., Kang, M. J., Moon, W. S., Kim, H. J., Jeong, Y. B., Sung, M. J., and Kim, W. (2013) Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int. 83, 50-62
41. Strutz, F., and Zeisberg, M. (2006) Renal fibroblasts and myofibroblasts in chronic kidney disease. J. Am. Soc. Nephrol. 17, 2992-2998
42. Rodemann, H. P., and Müller, G. A. (1991) Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am. J. Kidney Dis. 17, 684-686
43. Müller, G. A., and Rodemann, H. P. (1991) Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am. J. Kidney Dis. 17, 680-683
44. Aldigier, J. C., Kanjanbuch, T., Ma, L. J., Brown, N. J., and Fogo, A. B. (2005) Regression of existing glomerulosclerosis by inhibition of aldosterone. J. Am. Soc. Nephrol. 16, 3306-3314
45. Ma, L. J., Nakamura, S., Aldigier, J. C., Rossini, M., Yang, H., Liang, X., Nakamura, I., Marcantoni, C., and Fogo, A. B. (2005) Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J. Am. Soc. Nephrol. 16, 966-976
46. Fioretto, P., Steffes, M. W., Sutherland, D. E., Goetz, F. C., and Mauer, M. (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N. Engl. J. Med. 339, 69-75
47. Strutz, F., Heeg, M., Kochsiek, T., Siemers, G., Zeisberg, M., and Müller, G. A. (2000) Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts. Nephrol. Dial. Transplant. 15, 1535-1546
48. Heldin, C. H., and Westermark, B. (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316
49. Andrae, J., Gallini, R., and Betsholtz, C. (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22, 1276-1312
50. Wu, M. J., Wen, M. C., Chiu, Y. T., Chiou, Y. Y., Shu, K. H., and Tang, M. J. (2006) Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int. 69, 2029-2036
51. Lu, X., Gao, B., Wang, Y., Liu, Z., Yasui, T., Liu, P., Liu, J., Emmanuel, N., Zhu, Q., and Xiao, C. (2012) Renal tubular epithelial cell injury, apoptosis and inflammation are involved in melamine-related kidney stone formation. Urol. Res. 40, 717-723
52. Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., and West, A. B. (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C9
53. González-Cuadrado, S., Bustos, C., Ruiz-Ortega, M., Ortiz, A., Guijarro, C., Plaza, J. J., and Egido, J. (1996) Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis. Clin. Exp. Immunol. 106, 518-522
54. Krensky, A. M., and Ahn, Y. T. (2007) Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat. Clin. Pract. Nephrol. 3, 164-170
55. Konda, R., Sato, H., Sakai, K., Sato, M., Orikasa, S., and Kimura, N. (1999) Expression of platelet-derived endothelial cell growth factor and its potential role in up-regulation of angiogenesis in scarred kidneys secondary to urinary tract diseases. Am. J. Pathol. 155, 1587-1597
56. Yazdani, S., Navis, G., Hillebrands, J.L., van Goor, H., and van den Born J. (2014) Lymphangiogenesis in renal diseases: passive bystander or active participant? Expert Rev. Mol. Med. 25, 16:e15.
57. Zhang, G., Kim, H., Cai, X., Lopez-Guisa, J. M., Carmeliet, P., and Eddy, A. A. (2003) Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. J. Am. Soc. Nephrol. 14, 1234-1253
58. Tanaka, T., and Nangaku, M. (2013) Angiogenesis and hypoxia in the kidney. Nat. Rev. Nephrol. 9, 211-222
59. Kida, Y., Tchao, B. N., and Yamaguchi, I. (2014) Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. Pediatr. Nephrol. 29, 333-342
60. Shao, X., and Liu, C. (2006) Influence of IFN-alpha and IFN-gamma on lymphangiogenesis. J. Interferon Cytokine Res. 26, 568-574
61. Kerjaschki, D. (2014) The lymphatic vasculature revisited. J. Clin. Invest. 124, 874-877
62. Beljaars, L., Weert, B., Geerts, A., Meijer, D. K., and Poelstra, K. (2003) The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue. Biochem. Pharmacol. 66, 1307-1317
63. Ahmed, C. M., Burkhart, M. A., Mujtaba, M. G., Subramaniam, P. S., and Johnson, H. M. (2003) The role of IFNgamma nuclear localization sequence in intracellular function. J. Cell Sci. 116, 3089-3098
64. Subramaniam, P. S., Mujtaba, M. G., Paddy, M. R., and Johnson, H. M. (1999) The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence. J. Biol. Chem. 274, 403-407
65. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., and Schreiber, R. D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264
66. Johnson, H. M., Torres, B. A., Green, M. M., Szente, B. E., Siler, K. I., Larkin III, J., and Subramaniam, P. S. (1998) Cytokinereceptor complexes as chaperones for nuclear translocation of signal transducers. Biochem. Biophys. Res. Commun. 244, 607-614